Study of co-encapsulated doxorubicin and curcumin poly(butyl cyanoacrylate) nanoparticles and reversion of multidrug resistance in MCF-7/ADR cell line

被引:0
|
作者
Wu, Jun [1 ]
Duan, Jing-Hua [2 ]
机构
[1] School of Chemical and Biological Engineering, Yancheng Institute of Technology, Yancheng, China
[2] Department of Pharmaceutical Sciences-Drug Development Division, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0596, United States
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:415 / 423
相关论文
共 50 条
  • [31] Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles
    Vahid Shafiei-Irannejad
    Nasser Samadi
    Roya Salehi
    Bahman Yousefi
    Mahdi Rahimi
    Abolfazl Akbarzadeh
    Nosratollah Zarghami
    Pharmaceutical Research, 2018, 35
  • [32] Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide) -d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles
    Shafiei-Irannejad, Vahid
    Samadi, Nasser
    Salehi, Roya
    Yousefi, Bahman
    Rahimi, Mahdi
    Akbarzadeh, Abolfazl
    Zarghami, Nosratollah
    PHARMACEUTICAL RESEARCH, 2018, 35 (06)
  • [33] Novel Nanostructured Lipid Carrier Co-Loaded with Doxorubicin and Docosahexaenoic Acid Demonstrates Enhanced in Vitro Activity and Overcomes Drug Resistance in MCF-7/Adr Cells
    Mussi, Samuel V.
    Sawant, Rupa
    Perche, Federico
    Oliveira, Monica C.
    Azevedo, Ricardo B.
    Ferreira, Lucas A. M.
    Torchilin, Vladimir P.
    PHARMACEUTICAL RESEARCH, 2014, 31 (08) : 1882 - 1892
  • [34] Novel Nanostructured Lipid Carrier Co-Loaded with Doxorubicin and Docosahexaenoic Acid Demonstrates Enhanced in Vitro Activity and Overcomes Drug Resistance in MCF-7/Adr Cells
    Samuel V. Mussi
    Rupa Sawant
    Federico Perche
    Mônica C. Oliveira
    Ricardo B. Azevedo
    Lucas A. M. Ferreira
    Vladimir P. Torchilin
    Pharmaceutical Research, 2014, 31 : 1882 - 1892
  • [35] REVERSAL EFFECTS OF MIFEPRISTONE ON MULTIDRUG RESISTANCE(MDR) IN DRUG-RESISTANT BREAST CANCER CELL LINE MCF7/ADR IN VITRO AND IN VIVO
    李大强
    潘丽华
    邵志敏
    Chinese Journal of Cancer Research, 2004, (02) : 18 - 23
  • [36] Discovery of 2,5-disubstituted furan derivatives featuring a benzamide motif for overcoming P-glycoprotein mediated multidrug resistance in MCF-7/ADR cell
    Yang, Zhikun
    Cai, Yue
    Mao, Shen
    Wu, Qihao
    Zhu, Mengdi
    Cao, Xiaoji
    Wei, Bin
    Tian, Jin-Miao
    Bao, Xiaoze
    Ye, Xinyi
    Chen, Jianwei
    Wang, Sijia
    Yu, Yanlei
    Zhang, Huawei
    Sun, Xuanrong
    Cui, Zi-Ning
    Li, Ya-Sheng
    Wang, Hong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 257
  • [37] Synergistic Therapy of Doxorubicin with Cationic Anticancer Peptide L-K6 Reverses Multidrug Resistance in MCF-7/ADR Cancer Cells In Vitro via P-glycoprotein Inhibition
    Wang, Che
    Huang, Lili
    Li, Ruojin
    Wang, Ying
    Wu, Xiaoxue
    Shang, Dejing
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2021, 27 (04) : 2291 - 2301
  • [38] Synergistic Therapy of Doxorubicin with Cationic Anticancer Peptide L-K6 Reverses Multidrug Resistance in MCF-7/ADR Cancer Cells In Vitro via P-glycoprotein Inhibition
    Che Wang
    Lili Huang
    Ruojin Li
    Ying Wang
    Xiaoxue Wu
    Dejing Shang
    International Journal of Peptide Research and Therapeutics, 2021, 27 : 2291 - 2301
  • [39] R eversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier
    Li, Jin-Ming
    Zhang, Wei
    Su, Hua
    Wang, Yuan-Yuan
    Tan, Cai-Ping
    Ji, Liang-Nian
    Mao, Zong-Wan
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 3147 - 3162
  • [40] Coformulation of Doxorubicin and Curcumin in Poly(D,L-lactide-co-glycolide) Nanoparticles Suppresses the Development of Multidrug Resistance in K562 Cells
    Misra, Ranjita
    Sahoo, Sanjeeb K.
    MOLECULAR PHARMACEUTICS, 2011, 8 (03) : 852 - 866